Marksans Pharma - MARKSANS, 524404 corporate action history

Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404

Falling Comet

Download real time

164.76 -2.25 (-1.35%)

39.14% Fall from 52W High

635.9K

NSE+BSE Volume

NSE 16 Mar, 2026 3:31 PM (IST)

Marksans Pharma Bonus history

Marksans Pharma has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Split history for Marksans Pharma

Marksans Pharma has split the face value 1 time since March 11, 2008. Marksans Pharma had last split the face value of its shares from ₹10 to ₹1 in 2008.The share has been quoting on an ex-split basis from March 11, 2008.

Ex-Date	Old FV	New FV	Record Date
11 Mar 2008	10	1	-

See all forthcoming Bonus and split

Dividend history for Marksans Pharma

Marksans Pharma has declared 12 dividends since Sept. 18, 2014.

In the past 12 months, Marksans Pharma has declared an equity dividend amounting to ₹0.80 per share.

At the current share price of ₹164.7600, Marksans Pharma's dividend yield is 0.49%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
01 Aug 2025	0.80	FINAL	01 Aug 2025	Equity Share
17 Sep 2024	0.60	FINAL	17 Sep 2024	Equity Share
07 Jun 2023	0.50	FINAL	07 Jun 2023	Equity Share
19 Aug 2022	0.25	FINAL	-	Equity Share
15 Sep 2021	0.25	FINAL	-	Equity Share
22 Sep 2020	0.10	FINAL	-	Equity Share
19 Sep 2019	0.05	FINAL	-	Equity Share
19 Sep 2018	0.05	FINAL	-	Equity Share
19 Sep 2017	0.05	FINAL	-	Equity Share
22 Sep 2016	0.12	FINAL	-	Equity Share
23 Sep 2015	0.12	FINAL	-	Equity Share
18 Sep 2014	0.10	FINAL	-	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Marksans Pharma

The latest board meeting for Marksans Pharma took place on 05 Feb 2026, for the purpose of Quarterly Results

Ex-Date	Purpose	Notes
05 Feb 2026	Quarterly Results	-
13 Nov 2025	Quarterly Results	-
12 Aug 2025	Quarterly Results	-
19 May 2025	Audited Results & Final Dividend	-
11 Feb 2025	Quarterly Results	-
12 Nov 2024	Quarterly Results	-
13 Aug 2024	Quarterly Results	-
30 May 2024	Audited Results & Final Dividend	-
13 Feb 2024	Quarterly Results	-
09 Nov 2023	Quarterly Results	-

See all Board Meetings for Marksans Pharma

Marksans Pharma Rights history

Marksans Pharma has not issued any rights since Jan 1, 2000.

See all Rights History for Marksans Pharma

Is Marksans Pharma Ltd. worth buying?

1439 Votes:

Buy 80.68%

Sell 10.08%

Hold 9.24%